Lancor Blockchain Platform (LSP) is a blockchain based ecosystem designed with the vision to make cancer screening available for everyone everywhere at a cost all can afford. Our world class team has come together to execute this grand but achievable goal. We are bringing a patented technology, based on Opto-magnetic Imaging Spectroscopy (OMIS), to market. This uses light to detect cancer at the molecular level and can identify pre-cancer in less than 30 seconds. Using our sister company Tumour Trace's CE marked multi cancer detection devices, combined with the Lancor Cancer Screening Platform, we can quickly make cancer screening available for everyone everywhere for around $10 per test. The Medici Token will power and validate each of the cancer screening tests. The price of the cancer tests will be fixed, and demand for Medici Tokens will increase dramatically as the Lancor CSP is launched later this year and testing begins. We are currently building the alpha version of the platform now with our technical and integration partner Parker Fitzgerald (http://parker-fitzgerald.com/) here in London.
We will be opening up the ICO to a closed group of participants. This is also the point that the ICO launch marketing will begin. We will be completing an extensive programme to raise awareness and anticipation in the build up to the ICO launch.
LBP MVP Platform Live
The Lancor Blockchain Platform MVP launch will go live. This will enable us to run an operational screening test on the blockchain platform. We will run testing and development that will lead to an Alpha release in February 2019.
The Lancor ICO will officially launch to the market. The public sale will be available until we reach the hard cap amount or sale close date.
The ICO process will officially close unless we have already reached the hard cap earlier in the sale.
LBP Alpha Version Live
The Alpha version of the Lancor Blockchain Platform will officially go live. We will be able to increase the number of live tests and start working towards a general production release in November 2019.